NEW Paper Co-Authored By PI President & CEO

Journal of Controlled Release

Volume 199, 10 February 2015, Pages 37–44

Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases
"Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases."


Liang Jina, Ben J. Boyd, Paul J. White, Michael W. Pennington, Raymond S. Norton, Joseph A. Nicolazzo